Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple foot maneuver may ease stubborn heel pain

NCT ID NCT07544901

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a hands-on technique called navicular mobilization can reduce pain and improve foot function in people with plantar fasciitis and flat feet. 48 adults aged 18-32 will receive either the mobilization alone or combined with standard physical therapy for 4 weeks. Researchers will measure pain, foot function, and foot position changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 32 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants between 18 to 32 years of age. * Plantar fasciitis with flat foot. * Positive Flat foot cases diagnosed with foot print measurement * Both males and females * Unilateral or bilateral involvement with chronic plantar fasciitis * Diagnosed case of plantar fasciitis will be taken with navicular drop * Navicular Drop (ND) of \> 10mm Exclusion Criteria: * Patients with Peripheral vascular diseases * Patients with History of fractures in the lower limb * Patients with Skin infections and wounds on the foot * Patients with any neurological deficit involving foot * Patients with a history of foot or ankle surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Navicular bone are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Lahore Teaching Hospital

    Lahore, Punjab Province, 55150, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.